Medicines

Fulltext search

For help on how to get the results you want, see our search tips.

Search results

Categories

Human (796) Apply Human filter Veterinary (34) Apply Veterinary filter

Medicine name

Active substance / international non-proprietary name (INN) / common name

Medicine

European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Summaries of opinion Remove Summaries of opinion filter Paediatric investigation plans Remove Paediatric investigation plans filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter Direct healthcare professional communication Remove Direct healthcare professional communication filter Withdrawn applications (66) Apply Withdrawn applications filter

Product number

Patient safety

Yes (4) Apply Yes filter

Authorisation status

Authorised (398) Apply Authorised filter Refused (15) Apply Refused filter Withdrawn (57) Apply Withdrawn filter

ATC code

Species

Marketing authorisation date

From:

To:

Marketing authorisation holder

Pharmacotherapeutic group

Date of opinion

From:

To:

Opinion status

Positive (19) Apply Positive filter

Application type

Initial authorisation (9) Apply Initial authorisation filter Post-authorisation (10) Apply Post-authorisation filter

PIP decision type

P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) (9) Apply P: decision agreeing on a investigation plan, with or without partial waiver(s) and or deferral(s) filter PM: decision on the application for modification of an agreed PIP (73) Apply PM: decision on the application for modification of an agreed PIP filter RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) (1) Apply RW: decision refers to a refusal on a request for waiver in all age groups for the listed condition(s) filter W: decision granting a waiver in all age groups for all conditions or indications (18) Apply W: decision granting a waiver in all age groups for all conditions or indications filter

PIP condition / indication

Pharmaceutical form(s)

Route(s) of administration

Decision date

From:

To:

PIP compliance check

Yes (10) Apply Yes filter

Compliance procedure number

Orphan designation – intended use

Orphan decision number

Orphan designation status

Positive (223) Apply Positive filter Withdrawn (1) Apply Withdrawn filter

Referral name

Referral status

European Commission final decision (6) Apply European Commission final decision filter Under evaluation (1) Apply Under evaluation filter

Referral safety status

Yes (3) Apply Yes filter

Referral type

Article 31 referrals (4) Apply Article 31 referrals filter Article 20 procedures (3) Apply Article 20 procedures filter

Referral reference number

Referral decision making model

PRAC-CHMP-EC (6) Apply PRAC-CHMP-EC filter

Referral authorisation model

Centrally and nationally authorised products (mixed) (4) Apply Centrally and nationally authorised products (mixed) filter Centrally authorised product(s) (3) Apply Centrally authorised product(s) filter

Referral PRAC recommendation

Risk minimisation measures (3) Apply Risk minimisation measures filter Variation (1) Apply Variation filter

Referral procedure start date

From:

To:

Referral PRAC recommendation date

From:

To:

Medicine type

Accelerated assessment Remove Accelerated assessment filter Exceptional circumstances Remove Exceptional circumstances filter Generic Remove Generic filter Orphan medicine Remove Orphan medicine filter Additional monitoring (699) Apply Additional monitoring filter Biosimilar (82) Apply Biosimilar filter Conditional approval (108) Apply Conditional approval filter

Related medicine

Therapeutic area

Last updated

From:

To:

This week This month Last week Last month

First published

From:

To:

830 results

Remove all filtersRemove all filters

Medicine European public assessment reports (EPAR) Remove European public assessment reports (EPAR) filter Orphan designations Remove Orphan designations filter Referrals Remove Referrals filter Paediatric investigation plans Remove Paediatric investigation plans filter Summaries of opinion Remove Summaries of opinion filter Direct healthcare professional communication Remove Direct healthcare professional communication filter

Medicine type Exceptional circumstances Remove Exceptional circumstances filter Orphan medicine Remove Orphan medicine filter Accelerated assessment Remove Accelerated assessment filter Generic Remove Generic filter

Sort by

List item

Human medicine European public assessment report (EPAR): Levetiracetam Sun (updated)

levetiracetam, Epilepsy
Date of authorisation: 14/12/2011, , Revision: 15, Authorised, Last updated: 25/06/2021
List item

Human medicine European public assessment report (EPAR): Crysvita (updated)

Burosumab, Hypophosphatemia, Familial, Hypophosphatemic Rickets, X-Linked Dominant
Date of authorisation: 19/02/2018, , , , Revision: 8, Authorised, Last updated: 25/06/2021
List item

Human medicine European public assessment report (EPAR): Grepid (updated)

clopidogrel (as besilate), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 27/07/2009, , Revision: 22, Authorised, Last updated: 23/06/2021
List item

Human medicine European public assessment report (EPAR): Epidyolex (updated)

Cannabidiol, Lennox Gastaut Syndrome, Epilepsies, Myoclonic
Date of authorisation: 19/09/2019, , Revision: 7, Authorised, Last updated: 23/06/2021
List item

Human medicine European public assessment report (EPAR): Pregabalin Sandoz (updated)

pregabalin, Anxiety Disorders, Neuralgia, Epilepsy
Date of authorisation: 19/06/2015, , Revision: 7, Authorised, Last updated: 23/06/2021
List item

Human medicine European public assessment report (EPAR): Fintepla (updated)

Fenfluramine hydrochloride, Epilepsies, Myoclonic
Date of authorisation: 18/12/2020, , , Revision: 1, Authorised, Last updated: 23/06/2021
List item

Human medicine European public assessment report (EPAR): Kisplyx (updated)

lenvatinib mesilate, Carcinoma, Renal Cell
Date of authorisation: 25/08/2016, , Revision: 15, Authorised, Last updated: 23/06/2021
List item

Human medicine European public assessment report (EPAR): NexoBrid (updated)

proteolytic enzymes enriched in bromelain, Debridement
Date of authorisation: 18/12/2012, , , Revision: 11, Authorised, Last updated: 23/06/2021
List item

Human medicine European public assessment report (EPAR): Levetiracetam ratiopharm (updated)

levetiracetam, Epilepsy
Date of authorisation: 26/08/2011, , Revision: 12, Authorised, Last updated: 22/06/2021
List item

Human medicine European public assessment report (EPAR): Levetiracetam Actavis (updated)

levetiracetam, Epilepsy
Date of authorisation: 03/10/2011, , Revision: 16, Authorised, Last updated: 22/06/2021
List item

Human medicine European public assessment report (EPAR): Waylivra (updated)

Volanesorsen sodium, Hyperlipoproteinemia Type I
Date of authorisation: 03/05/2019, , , , Revision: 3, Authorised, Last updated: 22/06/2021
List item

Human medicine European public assessment report (EPAR): Votubia (updated)

everolimus, Tuberous Sclerosis
Date of authorisation: 02/09/2011, , Revision: 28, Authorised, Last updated: 21/06/2021
List item

Human medicine European public assessment report (EPAR): Clopidogrel Taw Pharma (previously Clopidogrel Apotex) (updated)

clopidogrel (as besilate), Peripheral Vascular Diseases, Stroke, Myocardial Infarction
Date of authorisation: 16/10/2009, , Revision: 21, Authorised, Last updated: 21/06/2021
List item

Human medicine European public assessment report (EPAR): Ayvakyt (updated)

avapritinib, Gastrointestinal Stromal Tumors
Date of authorisation: 24/09/2020, , , Revision: 2, Authorised, Last updated: 21/06/2021
List item

Human medicine European public assessment report (EPAR): Opsumit (updated)

Macitentan, Hypertension, Pulmonary
Date of authorisation: 20/12/2013, , Revision: 18, Authorised, Last updated: 18/06/2021
List item

Human medicine European public assessment report (EPAR): Palynziq (updated)

Pegvaliase, Phenylketonurias
Date of authorisation: 03/05/2019, , , Revision: 2, Authorised, Last updated: 17/06/2021
List item

Human medicine European public assessment report (EPAR): Ofev (updated)

nintedanib, Idiopathic Pulmonary Fibrosis
Date of authorisation: 14/01/2015, , Revision: 19, Authorised, Last updated: 17/06/2021
List item

Veterinary medicine European public assessment report (EPAR): Emdocam (updated)

meloxicam, Horses, Pigs, Cattle
Date of authorisation: 18/08/2011, , Revision: 8, Authorised, Last updated: 16/06/2021
List item

Human medicine European public assessment report (EPAR): Vimizim (updated)

recombinant human n-acetylgalactosamine-6-sulfatase, Mucopolysaccharidosis IV
Date of authorisation: 27/04/2014, , , Revision: 12, Authorised, Last updated: 16/06/2021
List item

Human medicine European public assessment report (EPAR): Blincyto (updated)

blinatumomab, Precursor Cell Lymphoblastic Leukemia-Lymphoma
Date of authorisation: 23/11/2015, , , Revision: 13, Authorised, Last updated: 15/06/2021
List item

Human medicine European public assessment report (EPAR): Zejula (updated)

Niraparib (tosilate monohydrate), Fallopian Tube Neoplasms, Peritoneal Neoplasms, Ovarian Neoplasms
Date of authorisation: 16/11/2017, , , Revision: 13, Authorised, Last updated: 11/06/2021
List item

Veterinary medicine European public assessment report (EPAR): Tulissin (updated)

tulathromycin, Cattle, Pigs, Sheep
Date of authorisation: 24/04/2020, , Revision: 2, Authorised, Last updated: 11/06/2021
List item

Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm (updated)

clopidogrel (as hydrogen sulfate), Myocardial Infarction, Acute Coronary Syndrome, Peripheral Vascular Diseases, Stroke
Date of authorisation: 18/02/2015, , Revision: 11, Authorised, Last updated: 10/06/2021
List item

Human medicine European public assessment report (EPAR): Cometriq (updated)

cabozantinib, Thyroid Neoplasms
Date of authorisation: 21/03/2014, , , , Revision: 22, Authorised, Last updated: 10/06/2021
List item

Human medicine European public assessment report (EPAR): Zalasta (updated)

olanzapine, Schizophrenia, Bipolar Disorder
Date of authorisation: 27/09/2007, , Revision: 18, Authorised, Last updated: 10/06/2021

Load more

830 results

Human medicine European public assessment report (EPAR): Levetiracetam Sun (updated)

Human medicine European public assessment report (EPAR): Crysvita (updated)

Human medicine European public assessment report (EPAR): Grepid (updated)

Human medicine European public assessment report (EPAR): Epidyolex (updated)

Human medicine European public assessment report (EPAR): Pregabalin Sandoz (updated)

Human medicine European public assessment report (EPAR): Fintepla (updated)

Human medicine European public assessment report (EPAR): Kisplyx (updated)

Human medicine European public assessment report (EPAR): NexoBrid (updated)

Human medicine European public assessment report (EPAR): Levetiracetam ratiopharm (updated)

Human medicine European public assessment report (EPAR): Levetiracetam Actavis (updated)

Human medicine European public assessment report (EPAR): Waylivra (updated)

Human medicine European public assessment report (EPAR): Votubia (updated)

Human medicine European public assessment report (EPAR): Clopidogrel Taw Pharma (previously Clopidogrel Apotex) (updated)

Human medicine European public assessment report (EPAR): Ayvakyt (updated)

Human medicine European public assessment report (EPAR): Opsumit (updated)

Human medicine European public assessment report (EPAR): Palynziq (updated)

Human medicine European public assessment report (EPAR): Ofev (updated)

Veterinary medicine European public assessment report (EPAR): Emdocam (updated)

Human medicine European public assessment report (EPAR): Vimizim (updated)

Human medicine European public assessment report (EPAR): Blincyto (updated)

Human medicine European public assessment report (EPAR): Zejula (updated)

Veterinary medicine European public assessment report (EPAR): Tulissin (updated)

Human medicine European public assessment report (EPAR): Clopidogrel ratiopharm (updated)

Human medicine European public assessment report (EPAR): Cometriq (updated)

Human medicine European public assessment report (EPAR): Zalasta (updated)